Fondation Congolaise pour la Recherche Médicale, Brazzaville, Republic of Congo.
Malar J. 2012 Dec 7;11:410. doi: 10.1186/1475-2875-11-410.
In this first study conducted after the introduction of artemisinin-combination therapy (ACT), the major objective was to evaluate Plasmodium falciparum genetic diversity and multiplicity of infection in isolates from Congolese children between one and nine years of age enrolled and followed up for one year. The secondary objective was to characterize the msp2 profiles of P. falciparum isolates collected from successive malaria episodes in ten children who had four or more clinical episodes during the follow up.
Three-hundred and thirteen children residing in southern part of Brazzaville participated in this study. Blood samples were obtained from all children at enrollment and checked for P. falciparum infection. Based on the one year follow-up data, two clinical groups were considered according to the number of malaria episodes presented over the follow up period: "protected"(children who did not experience any episode) and "unprotected" (those who experienced more that two episodes). Therefore, the msp2 genetic diversity of P. falciparum isolates collected at enrollment in the two groups was characterized by allele-specific nested PCR and compared. The msp2 profiles of P. falciparum isolates collected from successive malaria episodes was also characterized by allele-specific nested PCR.
Forty-three percent of FC27 and fifty-seven percent of 3D7 in protected vs fifty-six percent of FC27 and forty-four percent of 3D7 in isolates from unprotected children were detected. Seven and two alleles belonging to the FC27, and six and three alleles belonging to 3D7 families were distinguished in isolates from protected and unprotected children respectively. The mean multiplicity of infection (MOI) values at inclusion for the msp2 locus was 1.29 and 1.43 for protected and unprotected children respectively. 43 isolates were obtained from the ten children who had four or more clinical episodes during the follow up. A total of 63 alleles or fragments corresponding to 57% (36/63) FC27 and 43% (27/63) 3D7 were detected. The variant 400bp of FC27 was the most prevalent. 46% (20/43), 42% (18/43), 2% (1/43) and 2% (1/43) of isolates were found to have 1, 2, 3 and 4 parasite genotypes respectively and the mean MOI was 1.78.
This study shows that the introduction of ACT in the Republic of Congo has reduced the MOI but not the genetic diversity of P. falciparum isolates from children living in Southern districts of Brazzaville.
在引入青蒿素联合疗法(ACT)后的第一项研究中,主要目标是评估来自 1 至 9 岁刚果儿童的疟原虫遗传多样性和感染多重性,这些儿童在随访期间被招募并随访了一年。次要目标是描述在随访期间发生 4 次以上临床发作的 10 名儿童中,从连续疟疾发作中采集的恶性疟原虫分离株的 msp2 图谱。
313 名居住在布拉柴维尔南部的儿童参加了这项研究。所有儿童在入组时都采集了血样,并检查是否存在疟原虫感染。根据一年的随访数据,根据随访期间出现的疟疾发作次数,将两组考虑为“受保护”(未发生任何发作的儿童)和“未受保护”(发生两次以上发作的儿童)。因此,通过等位基因特异性嵌套 PCR 对两组入组时采集的恶性疟原虫分离株的 msp2 遗传多样性进行了特征描述,并进行了比较。还通过等位基因特异性嵌套 PCR 对从连续疟疾发作中采集的恶性疟原虫分离株的 msp2 图谱进行了特征描述。
在受保护的儿童中,FC27 的 43%和 3D7 的 57%,以及在未受保护的儿童中,FC27 的 56%和 3D7 的 44%被检测到。在受保护和未受保护的儿童中,FC27 家族分别检测到 7 个和 2 个等位基因,3D7 家族分别检测到 6 个和 3 个等位基因。msp2 基因座的入组时平均感染多重性(MOI)值分别为受保护和未受保护儿童的 1.29 和 1.43。从随访期间发生 4 次以上临床发作的 10 名儿童中获得了 43 个分离株。共检测到 57%(36/63)的 FC27 和 43%(27/63)的 3D7 的 63 个等位基因或片段。FC27 的 400bp 变体最为普遍。43%(20/43)、42%(18/43)、2%(1/43)和 2%(1/43)的分离株分别具有 1、2、3 和 4 个寄生虫基因型,平均 MOI 为 1.78。
本研究表明,在刚果共和国引入 ACT 降低了生活在布拉柴维尔南部地区儿童的疟原虫分离株的 MOI,但没有降低遗传多样性。